The Analytical Challenges of the Biosimilar Boom

Media Coverage
BI-001093

Contract Pharma

The biosimilar industry is growing. Mario DiPaola, Sr. Scientific Director at Charles River, breaks down the imbalance in the industry and why we could see some major changes in Contract Pharma.

Read the full article